[Metameric macular and papular skin mastocytosis]. En savoir plus sur [Metameric macular and papular skin mastocytosis].
Improving Mutation Screening in Patients with Colorectal Cancer Predisposition Using Next-Generation Sequencing. En savoir plus sur Improving Mutation Screening in Patients with Colorectal Cancer Predisposition Using Next-Generation Sequencing.
Actionable Genes, Core Databases, and Locus-Specific Databases. En savoir plus sur Actionable Genes, Core Databases, and Locus-Specific Databases.
Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant. En savoir plus sur Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.
The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors. En savoir plus sur The Balance Between Cytotoxic T-cell Lymphocytes and Immune Checkpoint Expression in the Prognosis of Colon Tumors.
Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations. En savoir plus sur Guidelines for reporting secondary findings of genome sequencing in cancer genes: the SFMPP recommendations.
Clinical profile of comorbidity of rare diseases in a Tunisian patient: a case report associating incontinentia pigmenti and Noonan syndrome. En savoir plus sur Clinical profile of comorbidity of rare diseases in a Tunisian patient: a case report associating incontinentia pigmenti and Noonan syndrome.
[The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition]. En savoir plus sur [The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition].
Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study and implications for multigene panel testing. En savoir plus sur Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study and implications for multigene panel testing.
Clinical implications of CTNNA1 germline mutations in asymptomatic carriers. En savoir plus sur Clinical implications of CTNNA1 germline mutations in asymptomatic carriers.